Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Pathways' Picks

MDUFA Meeting, Companion Dx 510(k)s, Next-Gen Sequencing in China, and More

In this week’s Pathways Picks: FDA schedules public launch meeting for MDUFA VI talks, and proposes to downclassify a category of companion diagnostics to 510(k) status; Medicare nationally covers respiratory assist devices; Brazil cancels upclassified IVD certifications; China issues guidance on next-generation sequencing classifications; South Korea details consultation procedures; and more.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Emerging Markets

The Digest: May 2025

In this month's news, expanded indication clearances from Intuitive and Element Science; Edwards Lifesciences gets the OK for asymptomatic patients, Safe Life grows its European footprint, and more.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More